Moreover, the positive correlation of the presence of EBV genetic material with the percentage of lymphocytes expressing PD-1 (CD4+ T lymphocytes in the blood and CD4+ and CD8+ T lymphocytes in the laryngeal cancer tissue and lymph nodes) indicated a negative role for EBV in the process of antitumor defense. This evidence concerns the gene CD4 and laryngeal carcinoma.